MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

12 Nov 2021 Evaluate
The sales moved up 34.25% to Rs. 1747.01 millions for the September 2021 quarter as compared to Rs. 1301.27 millions during the year-ago period.Net Profit witnessed a 125.12% growth almost the double from Rs. 112.26 millions to Rs. 252.72  millions  of same quarter last year.Operating profit surged to 484.09 millions from the corresponding previous quarter of 245.85 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1747.01 1301.27 34.25 3377.02 2430.22 38.96 5631.78 4119.47 36.71
Other Income 13.55 9.16 47.93 26.41 17.28 52.84 34.53 51.13 -32.47
PBIDT 484.09 245.85 96.90 941.34 468.39 100.97 1245.63 850.33 46.49
Interest 48.21 27.20 77.24 97.83 56.70 72.54 111.62 122.11 -8.59
PBDT 435.88 218.65 99.35 843.51 411.69 104.89 1134.01 728.22 55.72
Depreciation 80.90 56.11 44.18 160.85 111.05 44.84 222.82 220.66 0.98
PBT 354.98 162.54 118.40 682.66 300.64 127.07 911.19 507.56 79.52
TAX 102.26 50.28 103.38 197.95 96.35 105.45 301.55 180.67 66.91
Deferred Tax 27.26 20.28 34.42 52.95 41.35 28.05 141.09 91.26 54.60
PAT 252.72 112.26 125.12 484.71 204.29 137.27 609.64 326.89 86.50
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 27.71 18.89 46.67 27.87 19.27 44.63 22.12 20.64 7.15
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..